These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 30552955)

  • 1. Critical role of Ca
    Tomita S; Sekiguchi F; Deguchi T; Miyazaki T; Ikeda Y; Tsubota M; Yoshida S; Nguyen HD; Okada T; Toyooka N; Kawabata A
    Toxicology; 2019 Feb; 413():33-39. PubMed ID: 30552955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ca
    Tomita S; Sekiguchi F; Kasanami Y; Naoe K; Tsubota M; Wake H; Nishibori M; Kawabata A
    Eur J Pharmacol; 2020 Dec; 888():173587. PubMed ID: 32971090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of tubulin polymerization and chronic inhibition of proteasome as citotoxicity mechanisms in bortezomib-induced peripheral neuropathy.
    Meregalli C; Chiorazzi A; Carozzi VA; Canta A; Sala B; Colombo M; Oggioni N; Ceresa C; Foudah D; La Russa F; Miloso M; Nicolini G; Marmiroli P; Bennett DL; Cavaletti G
    Cell Cycle; 2014; 13(4):612-21. PubMed ID: 24335344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of interleukin-1 beta as a key mediator in the upregulation of Cav3.2-USP5 interactions in the pain pathway.
    Stemkowski PL; Garcia-Caballero A; Gadotti VM; M'Dahoma S; Chen L; Souza IA; Zamponi GW
    Mol Pain; 2017; 13():1744806917724698. PubMed ID: 28741432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting prokineticin system counteracts hypersensitivity, neuroinflammation, and tissue damage in a mouse model of bortezomib-induced peripheral neuropathy.
    Moschetti G; Amodeo G; Maftei D; Lattanzi R; Procacci P; Sartori P; Balboni G; Onnis V; Conte V; Panerai A; Sacerdote P; Franchi S
    J Neuroinflammation; 2019 Apr; 16(1):89. PubMed ID: 30995914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dorsal root ganglion neurons become hyperexcitable and increase expression of voltage-gated T-type calcium channels (Cav3.2) in paclitaxel-induced peripheral neuropathy.
    Li Y; Tatsui CE; Rhines LD; North RY; Harrison DS; Cassidy RM; Johansson CA; Kosturakis AK; Edwards DD; Zhang H; Dougherty PM
    Pain; 2017 Mar; 158(3):417-429. PubMed ID: 27902567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistological demonstration of CaV3.2 T-type voltage-gated calcium channel expression in soma of dorsal root ganglion neurons and peripheral axons of rat and mouse.
    Rose KE; Lunardi N; Boscolo A; Dong X; Erisir A; Jevtovic-Todorovic V; Todorovic SM
    Neuroscience; 2013 Oct; 250():263-74. PubMed ID: 23867767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cell-permeant peptide corresponding to the cUBP domain of USP5 reverses inflammatory and neuropathic pain.
    Garcia-Caballero A; Gadotti VM; Chen L; Zamponi GW
    Mol Pain; 2016; 12():. PubMed ID: 27130589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zinc deficiency promotes cystitis-related bladder pain by enhancing function and expression of Ca
    Ozaki T; Matsuoka J; Tsubota M; Tomita S; Sekiguchi F; Minami T; Kawabata A
    Toxicology; 2018 Jan; 393():102-112. PubMed ID: 29129814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of Ca
    Liu QY; Chen W; Cui S; Liao FF; Yi M; Liu FY; Wan Y
    Neurosci Res; 2019 May; 142():30-37. PubMed ID: 29684385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockade of T-type calcium channels by 6-prenylnaringenin, a hop component, alleviates neuropathic and visceral pain in mice.
    Sekiguchi F; Fujita T; Deguchi T; Yamaoka S; Tomochika K; Tsubota M; Ono S; Horaguchi Y; Ichii M; Ichikawa M; Ueno Y; Koike N; Tanino T; Nguyen HD; Okada T; Nishikawa H; Yoshida S; Ohkubo T; Toyooka N; Murata K; Matsuda H; Kawabata A
    Neuropharmacology; 2018 Aug; 138():232-244. PubMed ID: 29913186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of NLRP3 via STAT3-dependent histone acetylation contributes to painful neuropathy induced by bortezomib.
    Liu CC; Huang ZX; Li X; Shen KF; Liu M; Ouyang HD; Zhang SB; Ruan YT; Zhang XL; Wu SL; Xin WJ; Ma C
    Exp Neurol; 2018 Apr; 302():104-111. PubMed ID: 29339053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The molecular and cellular insight into the toxicology of bortezomib-induced peripheral neuropathy.
    Yan W; Wu Z; Zhang Y; Hong D; Dong X; Liu L; Rao Y; Huang L; Zhang X; Wu J
    Biomed Pharmacother; 2021 Oct; 142():112068. PubMed ID: 34463262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathological Mechanisms of Bortezomib-Induced Peripheral Neuropathy.
    Yamamoto S; Egashira N
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33477371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and Regulation of Cav3.2 T-Type Calcium Channels during Inflammatory Hyperalgesia in Mouse Dorsal Root Ganglion Neurons.
    Watanabe M; Ueda T; Shibata Y; Kumamoto N; Shimada S; Ugawa S
    PLoS One; 2015; 10(5):e0127572. PubMed ID: 25974104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The deubiquitinating enzyme USP5 modulates neuropathic and inflammatory pain by enhancing Cav3.2 channel activity.
    García-Caballero A; Gadotti VM; Stemkowski P; Weiss N; Souza IA; Hodgkinson V; Bladen C; Chen L; Hamid J; Pizzoccaro A; Deage M; François A; Bourinet E; Zamponi GW
    Neuron; 2014 Sep; 83(5):1144-58. PubMed ID: 25189210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TRPV1 Nociceptor Activity Initiates USP5/T-type Channel-Mediated Plasticity.
    Stemkowski P; García-Caballero A; Gadotti VM; M'Dahoma S; Huang S; Black SAG; Chen L; Souza IA; Zhang Z; Zamponi GW
    Cell Rep; 2016 Dec; 17(11):2901-2912. PubMed ID: 27974205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Synthetically Accessible Small-Molecule Inhibitor of USP5-Cav3.2 Calcium Channel Interactions with Analgesic Properties.
    Garcia-Caballero A; Gadotti VM; Ali MY; Bladen C; Gambeta E; Van Humbeck JF; MacCallum JL; Zamponi GW
    ACS Chem Neurosci; 2022 Feb; 13(4):524-536. PubMed ID: 35113527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro neurotoxicity by ropivacaine is reduced by silencing Cav3.3 T-type calcium subunits in neonatal rat sensory neurons.
    Wen X; Liang H; Li H; Ou W; Wang HB; Liu H; Li S
    Artif Cells Nanomed Biotechnol; 2018 Dec; 46(8):1617-1624. PubMed ID: 28974111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SUMOylation regulates USP5-Cav3.2 calcium channel interactions.
    Garcia-Caballero A; Zhang FX; Chen L; M'Dahoma S; Huang J; Zamponi GW
    Mol Brain; 2019 Aug; 12(1):73. PubMed ID: 31455361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.